|
ATCC
human dermal microvascular endothelial cells hmvec ![]() Human Dermal Microvascular Endothelial Cells Hmvec, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human dermal microvascular endothelial cells hmvec/product/ATCC Average 94 stars, based on 1 article reviews
human dermal microvascular endothelial cells hmvec - by Bioz Stars,
2026-03
94/100 stars
|
Buy from Supplier |
|
Lonza
human lung microvascular ecs (hmvec-l) ![]() Human Lung Microvascular Ecs (Hmvec L), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human lung microvascular ecs (hmvec-l)/product/Lonza Average 90 stars, based on 1 article reviews
human lung microvascular ecs (hmvec-l) - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Lonza
human lung microvascular endothelial cells (hmvecs) ![]() Human Lung Microvascular Endothelial Cells (Hmvecs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human lung microvascular endothelial cells (hmvecs)/product/Lonza Average 90 stars, based on 1 article reviews
human lung microvascular endothelial cells (hmvecs) - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Lonza
human lung microvascular endothelial cells hmvec-l ![]() Human Lung Microvascular Endothelial Cells Hmvec L, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human lung microvascular endothelial cells hmvec-l/product/Lonza Average 90 stars, based on 1 article reviews
human lung microvascular endothelial cells hmvec-l - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Lonza
human cardiac microvascular endothelial cells (hmvec-c) ![]() Human Cardiac Microvascular Endothelial Cells (Hmvec C), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human cardiac microvascular endothelial cells (hmvec-c)/product/Lonza Average 90 stars, based on 1 article reviews
human cardiac microvascular endothelial cells (hmvec-c) - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Lonza
d-hmvec-blneos ![]() D Hmvec Blneos, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/d-hmvec-blneos/product/Lonza Average 90 stars, based on 1 article reviews
d-hmvec-blneos - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Lonza
human lung microvascular endothelial cells (hmvec-l) ![]() Human Lung Microvascular Endothelial Cells (Hmvec L), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human lung microvascular endothelial cells (hmvec-l)/product/Lonza Average 90 stars, based on 1 article reviews
human lung microvascular endothelial cells (hmvec-l) - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Journal: Clinical Science (London, England : 1979)
Article Title: The loss of glycoprotein nonmetastatic melanoma protein B (GPNMB) alters endothelial cell permeability, metabolism, and survival during infectious challenge
doi: 10.1042/CS20256682
Figure Lengend Snippet: (A ) Interleukin-8 (IL-8), ( B ) tumor necrosis factor-alpha (TNF-α), ( C ) the tissue inhibitors of metalloproteinases 1 (TIMP1) concentrations, and ( D ) metalloproteinases-2, ( E ) metalloproteinases-3, and ( F ) metalloproteinases-9 activity in the culture medium of human microvascular endothelial cells (HMVECs) treated with scrambled siRNA (SCR) or GPNMB-targeting siRNA (siGPNMB), following stimulation with either vehicle or heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml) for 6 h. Each dot represents an individual sample. data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.
Article Snippet:
Techniques: Activity Assay
Journal: Clinical Science (London, England : 1979)
Article Title: The loss of glycoprotein nonmetastatic melanoma protein B (GPNMB) alters endothelial cell permeability, metabolism, and survival during infectious challenge
doi: 10.1042/CS20256682
Figure Lengend Snippet: (A ) Transendothelial electrical resistance (TEER) of human microvascular endothelial cells (HMVECs) treated with scrambled siRNA (siControl) or GPNMB-targeting siRNA (siGPNMB). ( B ) TEER measurements following lipopolysaccharide (LPS, 100 ng/ml) exposure, normalized to baseline values prior to stimulation. ( C ) TEER measurements after exposure to heat-killed E. coli (HKEC, 3 × 10⁸ cells/ml), normalized to baseline values. ( D-F ) Protein expression levels of ICAM, Integrin-β, and VE-Cadherin, with α-Tubulin used as a loading control. The number of samples used in each experiment ( n ) is expressed in parentheses or dots. Data are presented as mean ± SEM. Statistical analysis: Two-way ANOVA, followed by the Tukey post hoc test.
Article Snippet:
Techniques: Expressing, Control
Journal: Clinical Science (London, England : 1979)
Article Title: The loss of glycoprotein nonmetastatic melanoma protein B (GPNMB) alters endothelial cell permeability, metabolism, and survival during infectious challenge
doi: 10.1042/CS20256682
Figure Lengend Snippet: Control HMVEC cells (SCR) and treated with siRNA for GPNMB silencing (siGPNMB) were stimulated with vehicle or heat-killed E. coli (HKEC, 3 × 10 8 cells/ml) for 6 h. ( A ) Cell viability (CCK-8 assay) was assessed 1 h after the end of the entire protocol. ( B ) Proliferation (CCK-8 assay) was evaluated at 0-, 12-, and 24 h post-stimulation; the bar graph inserted in the figures represents the area under the curve (AUC) analysis of proliferation at 18 hours. ( C ) Cell migration was assessed using the Scratch-Wounding Assay at 2-, 6-, 12-, and 18 h post-stimulation; the bar graph inserted in the figures represents the quantification of the endpoint of the cell migration curve. ( D ) Representative images of the scratch-wounding assay at 0 and 18 h. ( E-G ) Phosphorylation levels of ERK, JNK, and p38 protein expression were normalized to their respective total protein levels. ( H ) PCNA protein expression normalized to α-Tubulin as a loading control. The number of samples used in each experiment ( n ) is expressed in parentheses or dots. Results are expressed as mean ± SEM. Statistics: Two-way ANOVA, followed by the Tukey post hoc test.
Article Snippet:
Techniques: Control, CCK-8 Assay, Migration, Phospho-proteomics, Expressing
Journal: Cellular and Molecular Life Sciences: CMLS
Article Title: Endothelial CHOP as a central mechanism in renovascular hypertension-induced vascular endothelial dysfunction and cardiac fibrosis
doi: 10.1007/s00018-025-05741-6
Figure Lengend Snippet: CHOP downregulation in human cardiac microvascular endothelial cells via CHOP-specific shRNAplasmid. (A) Western blot analysis of phosphorylated endothelial nitric oxide synthase (p-eNOS) was performed on cultured human cardiac microvascular endothelial cells transfected with CHOP-specific shRNA or a scrambled plasmid for 4 h. Following transfection, cells were stimulated with angiotensin II for an additional 4 h, followed by ATP stimulation for 15 min. (B) Western blot analysis of CHOP, inflammatory markers (COX2 and NLRP3), and β-actin in endothelial cells treated with CHOP-specific shRNA or scrambled plasmid for 4 h and subsequently stimulated with angiotensin II for 4 h. These data highlight the role of CHOP in modulating endothelial nitric oxide signaling and inflammatory responses under angiotensin II stimulation. Data are presented as mean ± SEM. Statistical analysis was performed using One-way ANOVA followed by Tukey’s post hoc test. Non-significant (ns): p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 for comparisons between (A) CL vs. CTL + Ang-II + ATP vs. CTL + ATP, shRNA CHOP vs. shRNA CHOP + Ang-II + ATP vs. shRNA CHOP + ATP vs. shRNA scramble vs. shRNA scramble + Ang-II + ATP vs. shRNA scramble + ATP, (B) CL vs. CTL + Ang-II, shRNA CHOP vs. shRNA CHOP + Ang-II vs. shRNA scramble vs. shRNA scramble + Ang-II ( n = 3)
Article Snippet: 0.3 × 10 6
Techniques: Western Blot, Cell Culture, Transfection, shRNA, Plasmid Preparation